Month: September 2020

Medigus: ScoutCam Announces Upgrade to OTCQB Venture Market

Written by Customer Service on September 14, 2020. Posted in Public Companies.

OMER, Israel, Sept. 14, 2020 (GLOBE NEWSWIRE) — Medigus Ltd. (NASDAQ:MDGS) (TASE:MDGS), a technology company developing minimally invasive tools and an innovator in direct visualization technology, today announced it was informed by ScoutCam Inc. (OTCQB: SCTC), Medigus’ subsidiary and a leading developer and manufacturer of customized visual solutions and supplementary technologies, that ScoutCam has been upgraded to the OTCQB Venture Market (OTCQB).“We are excited about ScoutCam’s official upgrade to the OTCQB Venture Market,” said Yaron Silberman, Chief Executive Officer of ScoutCam. “This elevates ScoutCam’s profile within the investment community, and we would like to thank our shareholders for their ongoing support as we reach this milestone.”ScoutCam is an Israeli-based company that develops and manufactures custom visual...

Sportsman’s Warehouse Holdings, Inc. to Present at Lake Street’s 4th Annual Best Ideas Growth (Big4) Virtual Conference

Written by Customer Service on September 14, 2020. Posted in Public Companies.

WEST JORDAN, Utah, Sept. 14, 2020 (GLOBE NEWSWIRE) — Sportsman’s Warehouse Holdings, Inc. (“Sportsman’s Warehouse” or the “Company”) (Nasdaq: SPWH) today announced that the Company has been invited to participate in Lake Street’s 4th annual Best Ideas Growth (Big4) Conference, being held on Thursday, September 17, 2020 on a virtual platform.Sportsman’s Warehouse management is scheduled to meet with investors via one-on-one and group meetings throughout the day.About Sportsman’s Warehouse Holdings, Inc.Sportsman’s Warehouse Holdings, Inc. is an outdoor specialty retailer focused on meeting the needs of the seasoned outdoor veteran, the first-time participant, and everyone in between. We provide outstanding gear and exceptional service to inspire outdoor memories.For press releases and certain additional...

Monoclonal Antibody Therapy Market to Reach USD 350.10 Billion by 2027; Increasing Number of Regulatory Approvals Will Aid Growth, says Fortune Business Insights™

Written by Customer Service on September 14, 2020. Posted in Mergers And Acquisitions.

Pune, Sept. 14, 2020 (GLOBE NEWSWIRE) — The global monoclonal antibodies therapy market size is projected to reach USD 350.10 billion by the end of 2027. The increasing prevalence of severe diseases such as cancer will create several opportunities for the companies operating in the market. The market was worth USD 123.03 billion in 2019 and will exhibit a CAGR of 14.0% during the forecast period, 2020-2027.Monoclonal antibodies are immune system proteins that are developed in laboratories. The therapeutic procedures associated with monoclonal antibodies are used in treatment of cancer. The advancements in ongoing clinical trials of drugs as well as treatment options related to these products will aid the growth of the overall market in the coming years.Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/monoclonal-antibody-therapy-market-102734The...

aTyr Pharma Announces $20 Million Common Stock Purchase Agreement with Aspire Capital Fund, LLC

Written by Customer Service on September 14, 2020. Posted in Public Companies.

Aspire Capital commits to purchase up to $20 Million of Common Stock over a period of up to 30 months.SAN DIEGO, Sept. 14, 2020 (GLOBE NEWSWIRE) — aTyr Pharma, Inc. (Nasdaq: LIFE), a biotherapeutics company engaged in the discovery and development of innovative medicines based on novel immunological pathways, today announced that it has entered into a Common Stock Purchase Agreement (the “Agreement”) providing for the sale of up to $20 million of common stock to Aspire Capital Fund, LLC, (Aspire Capital), a Chicago-based institutional investor and shareholder of aTyr. Under the terms of the Agreement, Aspire Capital has committed to purchase up to $20 million of aTyr’s common stock over a period of up to 30 months at prices based on the market price at the time of each sale, subject to certain terms and conditions. aTyr will...

Nonprofit Healthcare Organization with a Global Workforce Simplifies Security and Access to Enterprise Applications with BIO-key

Written by Customer Service on September 14, 2020. Posted in Public Companies.

WALL, N.J., Sept. 14, 2020 (GLOBE NEWSWIRE) — BIO-key International, Inc. (NASDAQ: BKYI), an innovative provider of identity and access management (IAM) solutions powered by biometrics, today announced that Partners in Health (PIH), a Boston-based nonprofit health care organization, selected BIO-key’s PortalGuard Identity and Access Management (IAM) solution to address their ongoing challenges with password resets and to improve authentication options to secure access to critical enterprise applications.PIH provides medical care and support in areas where the cost of healthcare is prohibitive to the community or geographic region. PIH considers quality health care as a universal human right and fights injustice, around the world, by providing care first to those who need it most.One of the primary challenges the PIH IT staff...

Ayala Pharmaceuticals to Host Virtual KOL Event Reviewing Interim Data Presented at ESMO 2020 from Ongoing Phase 2 ACCURACY Trial of AL101 for the Treatment of Recurrent/Metastatic Adenoid Cystic Carcinoma

Written by Customer Service on September 14, 2020. Posted in Public Companies.

REHOVOT, Israel and WILMINGTON, Del., Sept. 14, 2020 (GLOBE NEWSWIRE) — Ayala Pharmaceuticals, Inc. (NASDAQ: AYLA), a clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers, primarily in genetically defined patient populations, today announced that it will host a virtual Key Opinion Leader (KOL) event to review new interim data presented from the ongoing Phase 2 ACCURACY study of AL101 for the treatment of recurrent/metastatic (R/M) adenoid cystic carcinoma (ACC) harbouring Notch activating mutations at the European Society for Medical Oncology (ESMO) Virtual Congress 2020. The event will take place on Friday, September 18, 2020 at 8:00 am ET.The event will feature presentations from Ayala management and KOL, Dr. Alan L. Ho, M.D.,...

Purpose Advisor Solutions Closes Merger With Wealthsimple For Advisors

Written by Customer Service on September 14, 2020. Posted in Mergers And Acquisitions.

Combined entity provides advisors access to leading technology and partnershipsAgreement unites two experienced teams and technology to further strengthen leadership in advisor and portfolio manager services in CanadaTORONTO, Sept. 14, 2020 (GLOBE NEWSWIRE) — Today, Purpose Advisor Solutions (“PAS”) and Wealthsimple for Advisors (“W4A”) announced they have completed their merger into a single business. The new entity will be entirely focused on independent advisors and portfolio managers under Purpose Advisor Solutions and will provide enhanced technology-enabled portfolio and account management solutions. All clients on the W4A platform have been successfully transitioned to PAS’s registered portfolio manager, Harness Investment Management, and Fidelity Clearing Canada’s custodial platform.Purpose Advisor...

Verizon to acquire Tracfone

Written by Customer Service on September 14, 2020. Posted in Mergers And Acquisitions.

NEW YORK, Sept. 14, 2020 (GLOBE NEWSWIRE) — Verizon (NYSE: VZ) announced today that it has entered into an agreement with America Movil to acquire Tracfone, the leading pre-paid and value mobile provider in the U.S. The acquisition expands Verizon’s portfolio into the value segment, bringing enhanced access to its industry-leading wireless network and comprehensive suite of mobility products and services to a new customer base.Tracfone is the largest reseller of wireless services in the US, serving approximately 21 million subscribers through a network of over 90,000 retail locations nationwide. A longtime partner of Verizon, more than 13 million Tracfone subscribers currently rely on Verizon’s wireless network through an existing wholesale agreement.Following the acquisition, Verizon expects to bring its award-winning 4G LTE and...

Optinose to Present at the Cantor Virtual Global Healthcare Conference

Written by Customer Service on September 14, 2020. Posted in Public Companies.

YARDLEY, Pa., Sept. 14, 2020 (GLOBE NEWSWIRE) — Optinose (NASDAQ:OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that Chief Executive Officer Peter Miller will present a company overview and business update at the Cantor Virtual Global Healthcare Conference on September 16, 2020, at 2:00 p.m. ET.To listen to a webcast of the presentation live, please visit the Investors page of the Optinose website.A replay of the webcast will be available for 30 days following the conclusion of the event.About OptinoseOptinose is a global specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat (ENT) and allergy specialists. To learn more, please visit www.optinose.com or follow us on Twitter and LinkedIn.Optinose...

Avadel Pharmaceuticals Announces FT218 Leadership Transition

Written by Customer Service on September 14, 2020. Posted in Public Companies.

Jordan Dubow, M.D. stepping down as CMO and will continue as a consultant to the Company through the FT218 NDA submission and reviewSeasoned industry veteran and Avadel Board member, Mark McCamish, M.D., Ph.D., to work with management and provide direct leadership of the FT218 programDUBLIN, Ireland, Sept. 14, 2020 (GLOBE NEWSWIRE) — Avadel Pharmaceuticals plc (Nasdaq: AVDL), a company focused on developing FT218, an investigational, once-nightly formulation of sodium oxybate designed to treat excessive daytime sleepiness and cataplexy in patients with narcolepsy, announced today that Jordan Dubow, M.D. will be stepping down as Chief Medical Officer to pursue another opportunity. He will continue in a consultancy role in order to support the Company through the filing, review and anticipated approval of the new drug application...

Month: September 2020

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals